TRCT
MGCD

Tower Research Capital (TRC)’s MGC Diagnostics Corporation MGCD Stock Holding History

Tower Research Capital (TRC)’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$812 – 4404
2017
Q2 		$1K Buy
+100
New +$823 ﹤0.01% 2592
2017
Q1 		– Sell
-208
Closed -$2K – 4475
2016
Q4 		$2K Sell
208
-12
-5% -$90 ﹤0.01% 3529
2016
Q3 		$2K Sell
220
-358
-62% -$2.47K ﹤0.01% 3211
2016
Q2 		$4K Buy
578
+533
+1,184% +$3.19K ﹤0.01% 3610
2016
Q1 		$0 Sell
45
-44
-49% -$290 ﹤0.01% 5469
2015
Q4 		$1K Sell
89
-501
-85% -$3.37K ﹤0.01% 4289
2015
Q3 		$4K Sell
590
-1,029
-64% -$5.86K ﹤0.01% 3039
2015
Q2 		$9K Buy
1,619
+1,287
+388% +$7.99K ﹤0.01% 2850
2015
Q1 		$2K Buy
332
+21
+7% +$146 ﹤0.01% 3911
2014
Q4 		$2K Buy
311
+181
+139% +$1.18K ﹤0.01% 3477
2014
Q3 		$1K Sell
130
-594
-82% -$4.6K ﹤0.01% 4239
2014
Q2 		$6K Buy
724
+497
+219% +$4.91K ﹤0.01% 2781
2014
Q1 		$3K Buy
227
+35
+18% +$396 ﹤0.01% 3737
2013
Q4 		$2K Buy
+192
New +$2.35K ﹤0.01% 4097

Other funds holding MGCD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Tower Research Capital (TRC)'s MGCD Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of MGC Diagnostics Corporation (MGCD) in Q3 2017, closing a stake of 100 shares — an estimated $812 sold.

Tower Research Capital (TRC) first reported a position in MGCD in Q4 2013 and held it in 14 quarters. The position peaked at $9K in Q2 2015. 19 funds tracked by Wall St. Rank hold MGCD as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining MGC Diagnostics Corporation position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 MGC Diagnostics Corporation shares in Q3 2017, an estimated $812.
  • Tower Research Capital (TRC) first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s MGC Diagnostics Corporation position peaked at $9K in Q2 2015.
  • 19 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.